First-Line Medication for Agitation in Elderly Hospitalized Patients
For elderly hospitalized patients with agitation, non-pharmacological interventions should be attempted first, followed by low-dose haloperidol (0.5-1 mg) as the first-line pharmacological treatment when medication is necessary. 1
Initial Assessment and Non-Pharmacological Approaches
Before administering medication, always:
Address reversible causes of agitation:
- Explore patient concerns and anxieties
- Ensure effective communication and orientation
- Provide adequate lighting
- Treat medical causes (hypoxia, urinary retention, constipation, pain)
- Review current medications for side effects
Implement non-pharmacological interventions:
- Create a calm, quiet environment
- Ensure adequate access to food, drink, and toileting
- Establish a predictable routine
- Use proper lighting and clear signage
- Document triggers using ABC (antecedent-behavior-consequences) charting
Pharmacological Management Algorithm
First-Line Treatment
- Haloperidol 0.5-1 mg orally at night and every 2 hours when required 1
- For elderly patients: start with 0.5 mg
- Maximum 5 mg daily in elderly patients
- Can be administered subcutaneously if unable to swallow
- Recent evidence suggests low-dose haloperidol (≤0.5 mg) is as effective as higher doses with fewer side effects 2
Second-Line Options (if haloperidol is ineffective or contraindicated)
Atypical Antipsychotics:
- Risperidone: 0.25-0.5 mg per day at bedtime; maximum 2 mg per day 1
- Quetiapine: 25 mg (immediate release) orally; can give q12h if scheduled dosing required 1
- Olanzapine: 2.5 mg per day at bedtime; maximum 10 mg per day 1
For Anxiety-Predominant Agitation:
- Lorazepam: 0.25-0.5 mg orally four times a day as required (maximum 2 mg in 24 hours) 1
- Only if benzodiazepines specifically indicated (e.g., alcohol withdrawal)
- Not first-line for delirium-related agitation
Important Considerations and Cautions
Medication Duration: Use antipsychotics at the lowest effective dose for the shortest possible duration 1
Monitoring Requirements:
- Evaluate daily with in-person examination
- Monitor for extrapyramidal symptoms, sedation, orthostatic hypotension
- Assess QTc prolongation risk with antipsychotics
Special Populations:
Key Cautions:
- Benzodiazepines should NOT be used as first-line treatment for agitation in elderly patients with delirium 1
- Antipsychotics carry FDA black box warnings for increased mortality in elderly patients with dementia
- Regular use of benzodiazepines can lead to tolerance, addiction, depression, cognitive impairment, and paradoxical agitation in about 10% of elderly patients 1
Efficacy Evidence:
Remember that medication should only be used when non-pharmacological approaches have failed or when the patient is at risk of harming themselves or others. The goal is to use the lowest effective dose for the shortest duration possible while continuing non-pharmacological interventions.